MHT Thrombotic Risks Differ by Route, Dose, and Duration - Medscape

MHT Thrombotic Risks Differ by Route, Dose, and Duration  MedscapeMenopausal Hormone Therapy Thrombotic Risk Varies by Dose, Route of Administration  MedPage TodayLipoprotein(a) Consistently Linked to Incident Venous Thromboembolism in New Study  HCPLiveHRT ‘ups higher clot risk’ in legs or lungs regardless of dose or duration  Nursing TimesUse of estrogen tablets could increase risk of blood clots, study finds  Newsday